Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Intravenous Lignocain and Intravenous Dexmedetomidine for Attenuation of Hemodynamic Stress Response to Direct Laryngoscopy and Endotracheal Intubation

NCT07385040 is registered in ClinicalTrials.gov with Shaheed Mohtarma Benazir Bhutto Institue of Trauma as lead sponsor.

NCT NCT07385040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07385040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Intravenous Lignocain and Intravenous Dexmedetomidine for Attenuation of Hemodynamic Stress Response to Direct Laryngoscopy and Endotracheal Intubation
Lead sponsor
Shaheed Mohtarma Benazir Bhutto Institue of Trauma
Phase
Phase 2/3
Overall status
Completed
Start date
April 13, 2023
Completion date
December 31, 2023
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension, mean arterial pressure, tachycardia